Carisma Therapeutics Inc (CARM) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Carisma Therapeutics Inc   (NASDAQ: CARM)


Carisma Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CARM Gross Profit Margin (Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
Y / Y Revenue Change 1236.78 %
Seq. Revenue Change -
Revenue In Millions $45.25
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 675
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2025 Gross Profit Margin



Observing third quarter 2025 results within Major Pharmaceutical Preparations industry 101 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
CARM's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 102
Healthcare Sector # 174
Overall # 675

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Sep 30 2025)  




Other Gross Profit Margin Profitability Ratios
CARM's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CARM's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CARM's Competitors
Gross Profit Margin Profit Margin for Carisma Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for CARM's Customers

You may also want to know
CARM's Annual Growth Rates CARM's Profitability Ratios CARM's Asset Turnover Ratio CARM's Dividend Growth
CARM's Roe CARM's Valuation Ratios CARM's Financial Strength Ratios CARM's Gross Profit Growth
CARM's Roa CARM's Inventory Turnover Ratio CARM's Growth Rates CARM's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2025 MRQ Gross ProfitSep 30 2025 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.